Abstract 2056: Large-scale whole genome sequencing of hepatocellular carcinoma reveals stepwise cancer evolution

作者
Seongyeol Park,Suk Kyun Hong,Joonoh Lim,YoungRok Choi,Boram Yi,Jaemo Koo,June‐Young Koh,Ryul Kim,Nam‐Joon Yi,Jeong Seok Lee,Kyung‐Suk Suh,Kwang‐Woong Lee,Young Seok Ju
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (7_Supplement): 2056-2056 被引量:1
标识
DOI:10.1158/1538-7445.am2023-2056
摘要

Abstract Liver cancer is a leading cause of death worldwide where somatic mutation plays a key role in tumorigenesis. As such, many recent researches have been conducted using DNA sequencing methods to study somatic mutations in liver cancer, such as whole-exome sequencing (WES), panel sequencing, and whole-genome sequencing (WGS). However, our understanding of genomic landscape of liver tumorigenesis has been limited by a low number of quality samples from diverse clinical contexts. Here, we explore comprehensive genomic landscape of liver cancer throughout its tumorigenesis using large-scale whole-genome sequencing of hepatocellular carcinoma (HCC) in various cancer stages and liver conditions. Total 500 patients of HCCs were enrolled in this study and whole-genome sequenced. 462 samples that passed quality control were included for final analysis. Most of the samples (427; 92%) were obtained from surgical resection and the rest (35; 8%) from liver transplantation. We used a standard WGS analysis pipeline from read mapping to variant calling of single-base substitution (SBS), indel, structural variation (SV), and copy number variation (CNV). Downstream data analyses were performed using in-house scripts with a particular focus on mutational signatures. To study how genome changes as HCC progresses, we classified samples into three groups by T stage: T1, T2, and T3/4. The number of samples for each group was 205 (44%), 222 (48%), and 35 (8%), respectively. There was no significant difference in the number of SBSs and indels, but the number of SVs was significantly higher in T3/4 (the mean of T1/2 vs. T3/4 = 51 vs. 93; p=0.001). Major mutational signatures were SBS5, 40 (both clock-like), 12 (unknown), and 22 (aristolochic acid) for SBSs and ID1, 2, 5 (all clock-like), and 3 (tobacco smoking) for indels. The proportion of ID2, characterized by 1bp deletion at homopolymer site, was increased in the samples of higher T stage (the mean proportion of T1/2 vs. T3/4=11% vs. 16%; p=0.01). The higher-stage samples also harbored more frequent whole-genome duplication (WGD) and loss of heterozygosity (LOH) (the frequency of WGD in T1/2 vs. T3/4=42% vs. 68%, p<0.001; the mean LOH fraction of T1/2 vs. T3/4=0.12 vs. 0.19, p<0.001). There was a significant enrichment of driver mutations of multiple genes (e.g., TP53, MTCP1, CCND3, etc.) in T3/4 group. Interestingly, in surgically resected T1 samples, ID2 proportion was the only significant contributor to early recurrence over tumor size, N stage, mean ploidy, and LOH fraction (n=199, p=0.05; Cox regression). Overall, we found that HCCs at different T stages exhibit some common and yet apparently distinguishing genomic features. We believe that the comprehensive genomic profile of HCC across cancer stages will provide deep insights into the genomic evolution of HCC and one day lend itself to clinicogenomic bases for better HCC management in the future. Citation Format: Seongyeol Park, Suk Kyun Hong, Joonoh Lim, YoungRok Choi, Boram Yi, Jaemo Koo, June-Young Koh, Ryul Kim, Nam-Joon Yi, Jeong Seok Lee, Kyung-Suk Suh, Kwang-Woong Lee, Young Seok Ju. Large-scale whole genome sequencing of hepatocellular carcinoma reveals stepwise cancer evolution [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2056.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
剪烛关注了科研通微信公众号
1秒前
1秒前
Zxy完成签到,获得积分10
1秒前
1秒前
大方的凌翠完成签到,获得积分10
2秒前
星辰大海的应助被任风采纳,获得10
2秒前
2秒前
3秒前
3秒前
调皮青荷完成签到,获得积分10
3秒前
止兮完成签到 ,获得积分10
4秒前
雪山大地发布了新的文献求助10
4秒前
小明同学发布了新的文献求助10
5秒前
无花果的应助被科研废人采纳,获得10
5秒前
康子浩发布了新的文献求助10
5秒前
zhangsiyu完成签到,获得积分10
5秒前
6秒前
流年发布了新的文献求助10
6秒前
6秒前
6秒前
6秒前
7秒前
Zxy发布了新的文献求助10
7秒前
7秒前
汉堡宝发布了新的文献求助10
8秒前
Hello的应助被小赞采纳,获得20
8秒前
Mahruk驳回了lanyu的应助
8秒前
XxX发布了新的文献求助10
8秒前
wg发布了新的文献求助10
8秒前
9秒前
www关闭了www的文献求助
9秒前
10秒前
10秒前
佳洛父亲完成签到,获得积分10
10秒前
10秒前
初(*^▽^*)心的应助被斯文若血采纳,获得10
10秒前
英姑的应助被亦禾子啊采纳,获得10
10秒前
可爱多发布了新的文献求助10
10秒前
77wlr发布了新的文献求助10
11秒前
养火花发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163835
求助须知:如何正确求助?哪些是违规求助? 9557925
关于积分的说明 21742693
捐赠科研通 7754454
什么是DOI,文献DOI怎么找? 3428350
关于科研通互助平台的介绍 2553034
邀请新用户注册赠送积分活动 2472982